These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10193949)

  • 1. Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome.
    Liebross RH; Pollack A; Lankford SP; Zagars GK; von Eschenbach AC; Geara FB
    Cancer; 1999 Apr; 85(7):1577-85. PubMed ID: 10193949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
    Liebross RH; Pollack A; Lankford SP; von Eschenbach AC; Zagars GK
    Urology; 1998 Oct; 52(4):647-52. PubMed ID: 9763087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era.
    Zagars GK; Pollack A; von Eschenbach AC
    Cancer; 1997 Apr; 79(7):1370-80. PubMed ID: 9083160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
    Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
    Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inaccuracies in assignment of clinical stage for localized prostate cancer.
    Reese AC; Sadetsky N; Carroll PR; Cooperberg MR
    Cancer; 2011 Jan; 117(2):283-9. PubMed ID: 21210472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the prognostic significance of transrectal ultrasound extracapsular extension in prostate cancer.
    Yoon F; Rodrigues G; D'Souza D; Radwan J; Lock M; Bauman G; Ash R; Venketesan V; Downey D; Stitt L; Weisz D; Izawa J
    Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):117-24. PubMed ID: 16523811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
    Zagars GK; Geara FB; Pollack A; von Eschenbach AC
    Cancer; 1994 Apr; 73(7):1904-12. PubMed ID: 7511040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
    Park SJ; Miyake H; Hara I; Eto H
    Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal ultrasound in the staging of clinical T3a prostate cancer.
    Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
    Eur J Surg Oncol; 2007 Feb; 33(1):79-82. PubMed ID: 17067773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
    S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
    Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
    Zagars GK; Pollack A; Kavadi VS; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):293-306. PubMed ID: 7538498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
    Zagars GK; Pollack A
    Urology; 1995 Mar; 45(3):476-83. PubMed ID: 7533459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A more advanced clinical stage is positively correlated with an increased prostate cancer detection rate.
    Roobol MJ; Kranse R; van der Cruijsen IW; Schröder FH
    Urology; 2002 Jan; 59(1):91-6. PubMed ID: 11796288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of transrectal ultrasound in preoperative staging of prostate cancer.
    Colombo T; Schips L; Augustin H; Gruber H; Hebel P; Petritsch PH; Hubmer G
    Minerva Urol Nefrol; 1999 Mar; 51(1):1-4. PubMed ID: 10222753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of transrectal ultrasound and digital rectal examination in the diagnosis of prostate cancer.
    Shapiro A; Lebensart PD; Pode D; Bloom RA
    Br J Radiol; 1994 Jul; 67(799):668-71. PubMed ID: 8062008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.